Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Joyce Leman, Shernaz Walton, Alison M. Layton, Kathleen A. Ward, Sandy McBride, Sandeep Cliff, Anthony Downs, Margarita Landeira & Anthony Bewley. (2020) The real world impact of adalimumab on quality of life and the physical and psychological effects of moderate-to-severe psoriasis: a UK prospective, multicenter, observational study. Journal of Dermatological Treatment 31:3, pages 213-221.
Read now
Read now
Elizabeth Adenubiova, Petr Arenberger, Petra Gkalpakioti, Monika Arenbergerova, Jitka Jircikova, Tomas Dolezal & Spyridon Gkalpakiotis. (2018) Psoriasis treatment with adalimumab in clinical practice: long-term experience in a center for biological therapy in the Czech Republic. Journal of Dermatological Treatment 29:6, pages 579-582.
Read now
Read now
Carlo Giovanni Carrera, Paolo Dapavo, Piergiorgio Malagoli, Luigi Naldi, Luisa Arancio, Francesca Gaiani, Colin Gerard Egan, Marco Di Mercurio & Angelo Cattaneo. (2018) PACE study: real-life Psoriasis Area and Severity Index (PASI) 100 response with biological agents in moderate-severe psoriasis. Journal of Dermatological Treatment 29:5, pages 481-486.
Read now
Read now
G. Carretero, L. Puig, J. M. Carrascosa, L. Ferrándiz, R. Ruiz-Villaverde, P. de la Cueva, I. Belinchon, E. Vilarrasa, R. del Rio, J. L. Sánchez-Carazo, A. López-Ferrer, F. Peral, S. Armesto, N. Eiris, J. Mitxelena, J. Vilar-Alejo, M. A. Martin & C. Soria. (2018) Redefining the therapeutic objective in psoriatic patients candidates for biological therapy. Journal of Dermatological Treatment 29:4, pages 334-346.
Read now
Read now
Articles from other publishers (10)
Lucas Guillo, Benoit Flachaire, Jérôme Avouac, Catherine Dong, Maria Nachury, Guillaume Bouguen, Anthony Buisson, Ludovic Caillo, Mathurin Fumery, Cyrielle Gilletta, Xavier Hébuterne, Pierre Lafforgue, David Laharie, Emmanuel Mahé, Hubert Marotte, Stéphane Nancey, Sébastien Ottaviani, Jean-Hugues Salmon, Guillaume Savoye, Mélanie Serrero, Mathieu Uzzan, Manuelle Viguier, Christophe Richez, Laurent Peyrin-Biroulet, Philipe Seksik, Thao Pham, Philippe Ah-Soune, Nadia Arab, Laurent Beaugerie, Loïs Bolko, Joelle Bonnet, Yoram Bouhnik, Anne Bourrier, Franck Brazier, Franck Carbonnel, Maeva Charkaoui, Isabelle Charlot-Lambrecht, Antoine Chupin, Alice Combier, Marion Couderc, Fabienne Coury-Lucas, Ariadne Desjeux, Catherine Dong, Nicolas Duveau, Anne Grasland, Jean-Charles Grimaud, Xavier Guennoc, Cécilia Landman, Isabelle Nion-Larmurier, Catherien Leberre, Romain Leenhardt, Aude Le Goffic, Henri Montaudie, Jacques Morel, Thierry Passeron, Jeanne-Marie Perotin Collard, Elodie Poisnel, Vincent Pradel, Martin Soubrier, Harry Sokol, Eric Toussirot, Caroline Trang, My-Linh Trans Minh, Sophie Trijau, Frank Verhoeven, Stéphanie Viennot & Daniel Wendling. (2023) Efficacy and safety of combination targeted therapies in immune-mediated inflammatory disease: the COMBIO study. Digestive and Liver Disease 55:1, pages 61-68.
Crossref
Crossref
Thao Pham & Benoit Flachaire. (2022) Quelle place pour les associations de traitements ciblés ?. Revue du Rhumatisme 89, pages A7-A9.
Crossref
Crossref
Débora Dorneles Cunha de Queiroz Turíbio, Francisco Clitson Sousa Oliveira, Sandra Maria Fonseca Barreto & Thaís Barros Felippe Jabour. (2021) Interstitial lung disease due to anti-TNF use in the treatment of psoriasis. Anais Brasileiros de Dermatologia 96:4, pages 447-450.
Crossref
Crossref
J. Seneschal, J.‐P. Lacour, A. Bewley, M. Faurby, C. Paul, G. Pellacani, C. De Simone, L. Horne, A. Sohrt, M. Augustin, E. Hammond & K. Reich. (2020) A multinational, prospective, observational study to estimate complete skin clearance in patients with moderate‐to‐severe plaque PSOriasis treated with BIOlogics in a REAL world setting (PSO‐BIO‐REAL). Journal of the European Academy of Dermatology and Venereology 34:11, pages 2566-2573.
Crossref
Crossref
Cristina Galache Osuna, Borja Gómez-Vila, Javier Aubán Pariente, Beatriz Vázquez Losada, Celia Gómez de Castro, Sheila Requena López, Álvaro de Dios Velázquez, Laura Palacios García, Lucía Ordoñez Fernández, Santiago Gómez Diez, Francisco Vázquez López & Jorge Santos-Juanes. (2020) Ustekinumab Drug Survival in Patients with Psoriasis: A retrospective Study of Real Clinical Practice. Medicina 56:11, pages 584.
Crossref
Crossref
Ajay Chopra, Debdeep Mitra, Reetu Agarwal, Neerja Saraswat, Pooja Chemburkar & Loknandini Sharma. (2020) Real-life efficacy and safety of biosimilar adalimumab (ZRC-3197) in patients with plaque psoriasis: A tertiary care center experience. Indian Dermatology Online Journal 11:2, pages 182.
Crossref
Crossref
M. Talamonti, M. Galluzzo, N. Bernardini, G. Caldarola, S. Persechino, F. Cantoresi, C.G. Egan, C. Potenza, K. Peris & L. Bianchi. (2018) Psoriasis Area and Severity Index response in moderate-severe psoriatic patients switched to adalimumab: results from the OPPSA study. Journal of the European Academy of Dermatology and Venereology 32:10, pages 1737-1744.
Crossref
Crossref
Maria C. Potenza, Ketty Peris, Enzo Berardesca, Luca Bianchi, Antonio Richetta, Nicoletta Bernardini, Clara De Simone, Miriam Teoli, Arianna Zangrilli, Sara D'epiro, Diego Orsini, Alessandra Narcisi, Sergio Chimenti & Antonio Costanzo. (2018) Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey. Dermatologic Therapy 31:1, pages e12565.
Crossref
Crossref
Martin Havmose & Simon Francis Thomsen. (2017) Development of paradoxical inflammatory disorders during treatment of psoriasis with TNF inhibitors: a review of published cases. International Journal of Dermatology 56:11, pages 1087-1102.
Crossref
Crossref
A. Chiricozzi, A. Zangrilli, M. Bavetta, L. Bianchi, S. Chimenti & R. Saraceno. (2017) Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. Journal of the European Academy of Dermatology and Venereology 31:2, pages 304-311.
Crossref
Crossref